Tradjenta is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Tradjenta is considered an adjunct treatment to diet and exercise. Tradjenta is also referred to by its drug name, Linagliptin.
Tradjenta is a dipeptidyl peptidase 4 (DPP-4) inhibitor. Tradjenta is believed to work by lowering blood glucose levels when they are elevated.
How do I take it?
Prescribing information states that Tradjenta is generally taken once daily with or without food.
Tradjenta comes in tablet form.
The FDA-approved label for Tradjenta lists common side effects including flu-like symptoms, upper respiratory infection, and headache.
Rare but serious side effects listed for Tradjenta include pancreatitis, liver problems, and systemic allergic reaction.
We never share your personal information with anyone.